Drug Trial Radar · NCT06577935
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
379
Actual
Start
Oct 31, 2024
Primary completion
Dec 2026
Study completion Mar 2028
Sponsor
- Lead sponsor
- Angitia BiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Aug 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 55 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to determine the effect of treatment with AGA2118 versus placebo at Month 12 on lumbar spine bone mineral density (BMD) in postmenopausal women with low bone mass.
Conditions
- Postmenopausal Osteoporosis
Interventions
AGA2118Drug
Subcutaneous injection
PlaceboOther
Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from Baseline to Month 12 in lumbar spine bone mineral densityTime frame: 12 months
Locations
23 sites in 4 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Center for Advanced Research & Education
Gainesville, Georgia
NM Clinical Research & Osteoporosis Center, Inc.
Albuquerque, New Mexico
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Puget Sound Osteoporosis Center
Burien, Washington
CIDIIM
Córdoba, Argentina
Centro de Investigaciones Medicas Mar del Plata CIM
Mar del Plata, Argentina
Centro Médico Dra Laura Maffei e Investigación Cliínica Aplicada
Buenos Aires, Argentina, Argentina
Consultorio de Investigacion Clinica EMO SRL
Buenos Aires, Argentina, Argentina
IDIM
Buenos Aires, Argentina, Argentina
Investigaciones Reumatologicas y Osteologicas SRL
Buenos Aires, Argentina, Argentina
Mautalen - Salud e Investigacion (Expertia S.A.)
Buenos Aires, Argentina, Argentina
Stat Research
Buenos Aires, Argentina, Argentina
Instituto Médico Strusberg
Córdoba, Argentina, Argentina
Futuremeds Gdynia
Gdynia, Poland
Krakowskie Centrum Medyczne
Krakow, Poland
Futuremeds Lodz
Lodz, Poland
Futuremeds Warszawa Centrum
Warsaw, Poland
Futuremeds Targowek
Warsaw, Poland
Futuremeds Wroclaw
Wroclaw, Poland
CE "Hospital #1" of Zhytomyr City Council
Kyiv, Ukraine, Ukraine
Medical Center Universal Clinic "Oberig" of "Kapytal" LCC
Kyiv, Ukraine, Ukraine
PSSE Medical Centre Pulse
Vinnytsia, Ukraine, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.